Objective: The purpose of this study was to investigate the genotype distribution of S. maltophilia isolates from patients with cystic fibrosis (CF) by repetitive sequencebased PCR using the DiversiLab ® System. Methods: Sputum samples (n = 787) from 169 CF patients were inoculated onto a selective medium for improved isolation of S. maltophilia. Suspected isolates were identified by established phenotypic methods, as well as by DNA sequencing. A total of 63 S. maltophilia isolates from 14 CF patients were detected. For genotyping, DNA extraction was performed with the UltraCleanTM microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA, USA), according to the manufacturer's instructions. DiversiLab ® bacterial DNA fingerprinting kit (bioMérieux, Marcy L'Etoile, France) was used for typing. The relatedness degree of the isolates was determined by cluster analysis using Pearson's Correlation coefficient. Isolates with a similarity of 95% were considered as "clinically related" (clone), and isolates with a similarity >98% were considered as "indistinguishable" genotypes. Results: DiversiLab profiles from all patients' isolates exhibited one dominant colonising/infecting clone. It was also observed that two patients (15%) had more than one genotype. Only a small proportion of isolates from different patients (n = 5) were indistinguishable genotypes (9.52%), suggesting either cross-transmission or a common source of exposure of unclear origin. Conclusions: CF patients possess a dominant S. maltophilia clone and genotypic variants may coexist. Further epidemiological studies are required to elucidate the route of colonisation/infection in CF patients. • define the prevalence of CF patients colonized by extended-spectrum betalactamase-producing Enterobacteriaceae • establish length of colonization • emphasise the role of such pathogens in spreading resistance determinants Material and Methods: Sputa of pts with CF and Schwachmann Syndrome found positive for Enterobacteriaceae producing extended-spectrum beta-lactamases were evaluated. Cultures were processed according to the National and International Guidelines for the research of bacteria and fungi. ESBL production was confirmed in accordance with CLSI recommendations. Pulsed field gel electrophoresis was used to define the clonal relationship. Results: Between 1 September 2010 and 30 August 2011, we evaluated the cultures of the respiratory secretions of 350 pts; 15 pts (13 CF and 2 with Schwachmann Syndrome, 9 males, average age 3.5 years, range 1−32 years) resulted colonized by Enterobacteria producing extended-spectrum beta-lactamases (13 Escherichia coli; 1 Klebsiella oxytoca; 1 K. pneumoniae). Prevalence rate was 4.2%; in 5 pts colonization was higher than 6 months and in 2 higher than 1 year. Three pts showed only 1 isolate; for the others the observation period was too short. Conclusions: In the last year, we observed an increase of number of pts colonized by Enterobacteria producing ESBL that have a key epidemiological role for spreading the resistance genetic determinants. As a long time persistence of such pathogens in CF lung makes it a reservoir of resistance determinants, strict infection control measures must be taken in order to avoid dissemination.
